• 8.6.2012 TheraJect was granted Phase II research fund from NSF for
    Sumatriptan Delivery Research Program till 2014.



  • 7.1.2011 TheraJect was granted research fund from NSF for Sumatriptan
    Delivery Research Program.

  • 7.10.2007 TheraJect presented two posters (1st and 2nd) at the 34th CRS
    Annual Meeting in Long Beach, California.

  • 6.5.2007 TheraJect Chief Technical Officer Dr. Sung-Yun Kwon presented
    TheraJect Interdermal Patch for Influenza at WHO Conference





  • 7.19.2006 TheraJect is part of the Patterson HIV Vaccine Development
    Consortium, which is funded by a grant from the Bill & Melinda Gates
    Foundation.

  • 7.15.2006 TheraJect was granted research fund from NIH/NIA for PTH
    Delivery  Research Program.



  • 6.5.2005 TheraJect presented at the 2005 AAPS National Biotechnology in
    San Francisco, California.

  • 10.26.2004 TheraJect  was granted research fund from NIAID for Biodefense
    Research Program.